Trans-Resveratrol.

Resveratrol is cleared rapidly by sulfotransferases and UDP-glucuronosyltransferases in gut wall and liver, and quercetin inhibits those same enzymes. Taken together, more resveratrol survives first pass as the parent stilbene.

Piperine inhibits intestinal UDP-glucuronosyltransferase activity, the main route that conjugates resveratrol before it reaches the circulation. Co-dosing raises the amount of unconjugated stilbene absorbed.

Sirtuin deacetylases consume NAD+ as an obligate co-substrate, and resveratrol acts on that same enzyme family. An NAD precursor supplies the cofactor the enzyme needs to keep turning over.

NR raises intracellular NAD+, the co-substrate every sirtuin reaction consumes. Pairing it with a stilbene that acts on sirtuins covers both the enzyme and the cofactor it runs on.

Resveratrol dampens platelet aggregation, and long chain omega-3 fatty acids shift eicosanoid balance in the same direction. Stacked at high intakes the effect on normal clotting adds up.

Ginkgolides antagonise platelet activating factor while resveratrol reduces platelet aggregation by a separate route. The two effects on normal clotting are additive rather than offsetting.

Nattokinase acts on fibrin while resveratrol acts on platelet aggregation, so the two touch different points of the same clotting sequence. Combining them compounds the effect.

Garlic organosulfur compounds inhibit platelet aggregation, the same normal process resveratrol dampens. The two together push further in one direction than either alone.

High intakes of alpha-tocopherol interfere with vitamin K dependent clotting factor activity, and resveratrol reduces platelet aggregation. The two act at different points and add up.

Phenolic hydroxyl groups bind ferric iron and form poorly absorbed complexes in the gut, the same mechanism by which tea polyphenols lower non-heme iron uptake. Separating the two doses avoids the competition.

Carnosic acid from rosemary was one of three components in the rodent complex studied alongside resveratrol, and it is a recognised Nrf2 activator in its own right. Two activators of the same transcriptional response can be dosed lower than either alone would need. Evidence sits at the rodent and mechanistic level.

Pterostilbene is the dimethylated analogue of resveratrol and engages the same sirtuin and AMPK signalling. Its two methoxy groups resist the phase two sulfation and glucuronidation that clears resveratrol quickly, giving a longer plasma presence. Formulators pair them to cover both a fast and a slower stilbene exposure.

Sirtuins are NAD-dependent deacetylases, so any sirtuin-directed activity of resveratrol is bounded by how much NAD the cell has on hand. Raising the substrate and modulating the enzyme are two different levers on one reaction. That is the textbook basis for pairing a stilbene with an NAD precursor.

Berberine activates AMPK indirectly by raising the cellular AMP to ATP ratio, while resveratrol reaches AMPK through sirtuin and phosphodiesterase-linked signalling. Two entry points into one energy sensor are additive in cell work. Human combination data is limited, so the confidence sits on the mechanism.

Alpha-lipoic acid works in both water and lipid phases and regenerates other antioxidants in the recycling network, while resveratrol acts largely through inducing endogenous antioxidant enzymes. One is a direct scavenger and the other is a transcriptional inducer, so they cover different parts of the same defence. Read this as complementary chemistry.

Resveratrol signalling raises PGC-1 alpha driven mitochondrial biogenesis, and coenzyme Q10 is a required electron carrier in the respiratory chains those new mitochondria build. Adding capacity and supplying the carrier address different halves of the same system. Both are commonly used with a lipid meal for absorption reasons.

Trans-resveratrol is poorly water soluble, so the fraction that dissolves into a lipid phase and enters mixed micelles is what reaches the enterocyte. A medium chain triglyceride vehicle provides that phase in a capsule or emulsion. Absorption is limited more by first-pass conjugation than by dissolution, so a vehicle helps at only one step.

Complexing a polyphenol with phospholipid produces a phytosome that disperses in the aqueous gut lumen while keeping the molecule in a lipid environment. Lecithin is the standard phospholipid source for that construction. The demonstrated effect is on dispersion and dissolution rate.

Melatonin induces superoxide dismutase and glutathione peroxidase and scavenges directly, overlapping with the antioxidant enzyme induction attributed to resveratrol. Both are commonly taken at night, which makes the pairing practical as well as mechanistic. Human combination data is thin.

Ascorbate operates in the aqueous phase and regenerates the tocopheroxyl radical at the membrane surface, sitting one step away from the lipid-phase chemistry where a stilbene radical forms. The two occupy different compartments of the same recycling network. This is redox chemistry, not a measured combined outcome.

Grape seed proanthocyanidins and grape skin stilbenes come from the same fruit and are routinely formulated together as a whole-grape polyphenol matrix. Proanthocyanidins are poorly absorbed and act largely in the gut lumen and through microbial metabolites, whereas resveratrol is absorbed and rapidly conjugated. Different absorption fates, overlapping chemistry.

Sulforaphane modifies cysteine residues on Keap1 directly, releasing Nrf2 to drive antioxidant response element transcription, and resveratrol reaches the same transcriptional programme by a different route. Two upstream inputs to one output. Confidence is on the pathway, which is well characterised in cell work.